Search Results

Minocycline for sporadic and hereditary cerebral amyloid angiopathy (BATMAN): study protocol for a placebo-controlled randomized double-blind trial.

• Authors : Voigt S; Department of Neurology, Leiden University Medical Center, Albinusdreef 2, 2300 RC, Leiden, The Netherlands. .; Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC, Leiden, The Netherlands. .

Subjects: Cerebral Amyloid Angiopathy*/Cerebral Amyloid Angiopathy*/Cerebral Amyloid Angiopathy*/diagnostic imaging ; Cerebral Amyloid Angiopathy*/Cerebral Amyloid Angiopathy*/Cerebral Amyloid Angiopathy*/drug therapy ; Cerebral Amyloid Angiopathy*/Cerebral Amyloid Angiopathy*/Cerebral Amyloid Angiopathy*/complications

• Source: Trials [Trials] 2023 Jun 05; Vol. 24 (1), pp. 378. Date of Electronic Publication: 2023 Jun 05.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium:

Record details

Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial.

• Authors : Koga T; Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan. .; Center for Bioinformatics and Molecular Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, 852-8523, Japan. .

Subjects: Drug Resistance*; Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*therapeutic use ; Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*therapeutic use

• Source: Trials [Trials] 2018 Dec 29; Vol. 19 (1), pp. 715. Date of Electronic Publication: 2018 Dec 29.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium:

Record details

Improving gait adaptability in patients with hereditary spastic paraplegia (Move-HSP): study protocol for a randomized controlled trial.

• Authors : van de Venis, Lotte¹ (AUTHOR) ; van de Warrenburg, Bart P. C.² (AUTHOR); Weerdesteyn, Vivian¹ (AUTHOR)

• Source: Trials. 1/7/2021, Vol. 22 Issue 1, p1-10. 10p. 2 Diagrams, 1 Chart.

Record details

Attention training for infants at familial risk of ADHD (INTERSTAARS): study protocol for a randomised controlled trial

• Authors : Patrick Bolton; Simona Salomone; Andrew Pickles

Subjects: medicine.medical_specialty; Infancy; DEFICIT HYPERACTIVITY DISORDER

• Source: TrialsGoodwin, A, Salomone, S, Bolton, P F, Charman, T, Jones, E, Pickles, A, Robinson, E J, Smith, T, Sonuga-Barke, E, Wass, S & Johnson, M H 2016, ' Attention

Record details

Implementation and evaluation of a nurse-led decision-coaching program for healthy breast cancer susceptibility gene (BRCA1/2) mutation carriers: a study protocol for the randomized controlled EDCP-BRCA study.

• Authors : Isselhard A; Institute of Health Economics and Clinical Epidemiology, University Hospital of Cologne, Cologne, Germany. .; Töpper M

Subjects: Genes, BRCA1* ; Genes, BRCA2* ; Nurse-Patient Relations*

• Source: Trials [Trials] 2020 Jun 08; Vol. 21 (1), pp. 501. Date of Electronic Publication: 2020 Jun 08.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium:

Record details

Evaluation of two evidence-based decision aids for female BRCA1/2 mutation carriers in Germany: study protocol for a randomised controlled parallel-group trial.

• Authors : Kautz-Freimuth S; Institute of Health Economics and Clinical Epidemiology, The University Hospital of Cologne, Gleueler Straße 176-178, 50935, Cologne, Germany. .; Redaèlli M

Subjects: BRCA1 Protein*/BRCA1 Protein*/BRCA1 Protein*/genetics ; BRCA2 Protein*/BRCA2 Protein*/BRCA2 Protein*/genetics ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/genetics

• Source: Trials [Trials] 2022 Feb 16; Vol. 23 (1), pp. 157. Date of Electronic Publication: 2022 Feb 16.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium:

Record details

VIA Family-a family-based early intervention versus treatment as usual for familial high-risk children: a study protocol for a randomized clinical trial.

• Authors : Müller AD; Research Unit, Child and Adolescent Mental Health Center, Lersø Parkallé 107, 1 th, 2100, Copenhagen, Capital Region of Denmark, Denmark. .; Gjøde ICT

Subjects: Child Behavior* ; Family Therapy* ; Resilience, Psychological*

• Source: Trials [Trials] 2019 Feb 08; Vol. 20 (1), pp. 112. Date of Electronic Publication: 2019 Feb 08.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium:

Record details

Attention training for infants at familial risk of ADHD (INTERSTAARS): study protocol for a randomised controlled trial.

• Authors : Goodwin A; Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, UK. .; Salomone S

Subjects: Attention* ; Child Development* ; Infant Behavior*

• Source: Trials [Trials] 2016 Dec 28; Vol. 17 (1), pp. 608. Date of Electronic Publication: 2016 Dec 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium:

Record details